Most platforms are databases with a search bar. ForesightRx is a continuously evolving intelligence engine — fed by boots-on-ground conference attendance, powered by AI matching, and delivered through human-facilitated deal execution.
The Living Loop
This is not a one-time database build. It is a continuously compounding intelligence cycle that gets smarter and more valuable with every conference we attend.
We travel to 12+ conferences annually — BIO International, BioChina, BIO-Europe, CPHI. We meet founders face-to-face.
We assess the science, the team, the data. Not every biotech makes it into our system. Quality over quantity, always.
Qualified assets enter our living database — tagged by therapeutic area, stage, modality, geography, and deal readiness.
Our AI maps indexed assets against active pharma BD theses in real time. Months of scouting compressed to minutes. High-fit matches surface automatically.
Warm introductions, CDAs, NCDs, meetings — all orchestrated. No cold outreach. No waiting. Deals move faster when both sides are pre-qualified.
Every engagement enriches the intelligence. Better matching, faster qualification, deeper insights. The loop compounds.
Your BD team spends weeks scrolling databases that were last updated months ago. We give you continuously refreshed, conference-sourced, AI-matched biotech assets — with context only boots-on-ground intelligence can provide.
Explore Pharma SolutionsTell us your therapeutic areas, preferred stage, modality, geography, and deal structure. Your thesis stays confidential — biotechs never see it.
At conferences worldwide, our team meets biotechs, assesses their science, and identifies the assets that fit your thesis — pre-qualified before you see them.
You receive qualified asset profiles with rationale, competitive context, and deal-readiness assessment. Discovery access via platform — not a database dump.
When you are ready to engage, we handle the positioning, confidential outreach, NCD exchange, and CDA facilitation. This is where the platform ends and the deal begins.
Meeting prep, due diligence dossiers, term benchmarking — we stay in the loop as the trusted bridge between both sides until the deal is done.
You spend $50K on a conference booth, hand out NCDs to everyone who walks by, and wait months for one callback. We put your asset directly in front of the pharma BD teams that are actively looking for what you have — without you having to leave your lab.
Explore PartneringWe sharpen your narrative: problem-patient-proof. Your science, reframed for the audience that actually writes cheques.
Epidemiology, competitive landscape, commercial scenarios — the intelligence pharma and investors expect before saying yes.
We identify the specific pharma companies most likely to care about your asset — based on their BD thesis, not guesswork.
Your confidential data stays with us until you approve each introduction. Pharma sees only what you want them to see, when you are ready.
Success-based model. We invest our time and resources first. You pay when a deal happens. Our incentives are fully aligned with yours.
The Compounding Advantage
More conferences attended. More biotechs qualified. More pharma theses mapped. Better matching. Faster deals. A compounding intelligence advantage that no static database can replicate.
Conferences Attended
More ground truth
Biotechs Qualified
Richer supply data
Pharma Theses
More demand signals
Deals Facilitated
Smarter matching
Tell us what you are looking for — we will come back with an honest assessment of whether and how we can help. No sales pitch. Just substance.